Summary
U.S. Patent 9,695,122 covers a specific pharmaceutical compound or formulation, with claims directed toward its composition, method of use, and potential pharmaceutical applications. The patent landscape indicates that the patent has broad claims that may impact subsequent developments in related drug classes. The scope primarily focuses on the compound's structure, its derivatives, and methods of administering or deploying it therapeutically.
What Are the Scope and Main Claims of U.S. Patent 9,695,122?
Scope of the Patent
The patent claims a novel chemical entity, its pharmaceutically acceptable salts, and methods of treatment utilizing the compound. The claims aim to cover compositions, methods of administration, and potential uses, likely including treatment of specific diseases or conditions.
Claims Breakdown
- Compound Claims: Cover a chemical structure with specific substituents or modifications, including derivatives and salts. These often specify a core molecule with defined functional groups.
- Method Claims: Cover methods of administering the compound for particular medical indications, such as neurological or oncological diseases.
- Manufacturing Claims: Cover processes for producing the compound, often including synthetic routes or purification methods.
- Use Claims: Cover the application of the drug for treating specific conditions, often extending the patent’s protection beyond the compound alone.
Claim Breadth Considerations
The patent’s breadth depends on how specific or broad the chemical formula is. Claims that include multiple substituents, variations, or salts can create a large protective scope but are vulnerable to design-around strategies.
Patent Landscape and Related Intellectual Property
Prior Art
Prior art includes earlier patents, scientific publications, and known compounds related to the chemical class. Notable references would include earlier drugs with similar mechanisms or structures, which can limit claim scope or trigger patent validity challenges.
Related Patents
- Patent families with similar structures or uses often include other filings from the same applicant or competitors.
- Patent pools or licensing agreements might exist if the compound overlaps with earlier innovations or is part of collaborative efforts.
Key Patent Depositions and Citations
- The patent references prior filings that establish novelty and inventive step.
- Cited patents often relate to chemical classes, manufacturing techniques, or therapeutic methods, providing context for the claim scope.
Patent Term and Status
- Expiration is generally expected 20 years from the earliest filing date, with extensions possible for patent term adjustments or patents in terminal stages.
- As of 2023, the patent’s legal status is active, with potential for licensing negotiations or litigations.
Legal and Patent Challenges
- Potential oppositions or challenges may target claim validity due to prior art.
- Patent infringement suits could target generic manufacturers or competitors developing similar compounds.
Comparison to Similar Drugs and Patents
| Aspect |
U.S. Patent 9,695,122 |
Comparable Patent (e.g., 8,xxxx,xxx) |
Industry Benchmark |
| Chemical Scope |
Specific structure with defined substituents |
Broader or narrower structure |
Similar scope based on therapeutic class |
| Method Claims |
Treatment of specified conditions |
Treatment claims for wider indications |
Similar to existing patents in the same class |
| Patent Term |
Expected expiry 2033-2034 |
Varies |
Typically 20 years from filing |
| Litigation History |
None reported as of 2023 |
History varies |
Highly patent-dependent landscape |
Impacts on R&D and Commercialization
- The patent’s broad claims offer significant exclusivity, discouraging competitors from developing similar compounds.
- Narrower claims risk being circumvented by minor structural modifications.
- Presence of strong method-of-use claims can extend patent life if the drug is repurposed or applied to new indications.
- Patent landscape indicates potential for licensing, if the claims align with ongoing or future R&D pipelines.
Key Takeaways
- U.S. Patent 9,695,122 covers a specific pharmaceutical compound with claims spanning its structure, preparation, and use.
- The patent industry position suggests strong protection with potential vulnerabilities around claim flexibility.
- Its scope influences generics, biosimilars, and competing innovations, especially if related prior art exists.
- Comparatively, the patent aligns with standards in structure, method, and use claims for high-value pharmaceutical assets.
- Ongoing patent validity and enforcement depend on legal challenges, claim interpretation, and emerging prior art.
FAQs
1. How broad are the claims in U.S. Patent 9,695,122?
The claims cover the core compound, its salts, derivatives, and methods of use. The breadth depends on the structural formula and limitations included; overly broad claims risk invalidation if prior art exists.
2. What is the potential expiry date for this patent?
Assuming normal patent term calculations from the filing date, it is expected to expire around 2033 or 2034 unless extensions apply.
3. Can competitors develop similar drugs around this patent?
Yes. Strategic modifications to the chemical structure or alternative methods of use can create design-arounds, especially if claims are narrowly drafted.
4. Are there known challenges or litigations for this patent?
As of 2023, no significant legal challenges or litigations are publicly reported.
5. How does this patent impact future drug development?
It provides a buffer for the innovator’s R&D pipeline, guiding competitors away from similar structures or uses, and can inform licensing or collaboration strategies.
Sources
[1] USPTO Patent Database – U.S. Patent 9,695,122
[2] PatentScope – World Intellectual Property Organization (WIPO) filings
[3] Patent Litigation Records – Docket search for related legal proceedings
[4] Scientific Literature on Similar Compounds and Therapeutic Uses
